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Abstract
Background: Real-time and dynamic assessment of an individual’s lipid homeostatic state in blood is complicated
due to the need to collect samples in a clinical environment. In the context of precision medicine and population
health, tools that facilitate sample collection and empower the individual to participate in the process are necessary
to complement advanced bioanalytical analysis. The dried blood spot (DBS) methodology via finger prick or heel
prick is a minimally invasive sample collection method that allows the relative ease and low cost of sample collection
as well as transport. However, it has yet to be integrated into broad scale personalized lipidomic analysis. Therefore, in
this study we report the development of a novel DBS high resolution MS/MSALL lipidomics workflow.
Methods: In this report we compared lipidomic analysis of four types of blood sample collection methods (DBS, venous
whole blood, serum, and plasma) across several parameters, which include lipidomics coverage of each matrix and the
effects of temperature and time on the coverage and stability of different lipid classes and molecular species. The novel
DBS-MS/MSALL lipidomics platform developed in this report was then applied to examine postprandial effects on the
blood lipidome and further to explore the temporal fluctuation of the lipidome across hours and days.
Results: More than 1,200 lipid molecular species from a single DBS sample were identified and quantified. The lipidomics
profile of the DBS samples is comparable to whole blood matrix. DBS-MS/MSALL lipidomic analysis in postprandial
experiments revealed significant alterations in triacylglyceride species. Temporal analysis of the lipidome at various times
in the day and across days identified several lipid species that fluctuate as a function of time, and a subset of lipid species
were identified to be significantly altered across hours within a day and within successive days of the week.
Conclusions: A novel DBS-MS/MSALL lipidomics method has been established for human blood. The feasibility and
application of this method demonstrate the potential utility for lipidomics analysis in both healthy and diverse diseases
states. This DBS MS-based lipidomics analysis represents a formidable approach for empowering patients and individuals
in the era of precision medicine to uncover novel biomarkers and to monitor lipid homeostasis.
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Background
For over two decades the dried blood spot (DBS) meth-
odology has commonly been used in the diagnosis of in-
born errors of metabolism [1–3]. Currently, more than
95% of newborns are screened for inherited metabolic
disorders using DBS in the United States [2, 4]. Using
this methodology blood samples are typically obtained
from heel or finger pricks and spotted onto filter paper
for collection and analysis. DBS offers several advantages
over conventional whole blood, plasma or serum sample
collection [5, 6]. For example, DBS sample collection is
minimally invasive and easy to perform (e.g. finger or
heel prick rather than venous puncture) and notably, it
can be done at home by patients or volunteers them-
selves after minimal training. In addition, a low volume
of blood (less than 20 μL) is needed to spot onto filter
paper compared to a minimum of 0.5 mL of blood in
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venous sampling. Lastly, DBS is relatively stable at ambi-
ent temperature, thus facilitating easy shipping and stor-
age of samples. As such, the application of DBS has been
developed for therapeutic drug monitoring [7, 8], pharma-
cokinetics [9], genomics [10], proteomics [11, 12], and
metabolomics [13].
The lipidome of human blood is comprised of thou-
sands of lipid molecular species [14]. Its homeostatic
regulation plays a pivotal role in numerous pathological
disease states, such as atherosclerosis, cancer, metabolic
diseases, and Alzheimer’s disease [15–20]. Lipidomic
analysis is largely based on electrospray ionization mass
spectrometry (ESI-MS) coupled with liquid chromatog-
raphy (LC) or using direct infusion, i.e., shotgun lipido-
mics [21–23]. Using the ESI-MS/MS strategy, lipid
molecular species can be identified by their characteris-
tic fragments (from the head group or fatty acid chains)
and their molecular weights. Typically, these types of
ions have been applied in precursor ion scanning, neu-
tral loss scanning, and multiple reaction monitoring ex-
periments to measure lipid species from human serum,
plasma, and whole blood [23, 24]. Traditional MS-based
lipidomics has been dominated by triple quadrupole in-
struments and require the pre-selection of specific ions
or multiple runs for the diverse capture of the lipidome.
Recently, a novel data-independent acquisition (DIA)
technique of mass spectrometry has been developed to
overcome this shortcoming by parallelizing the fragmen-
tation of all detectable ions within a certain m/z range
[25, 26]. With the combination of high-resolution MS,
DIA provides a powerful tool for shotgun lipidomics.
MS/MSALL is a direct infusion DIA technique, using a
hybrid quadrupole time-of-flight (QTOF) technology,
specifically designed for lipidomics [27, 28]. In MS/
MSALL, all precursors are selected in the Q1 quadrupole
at unit-based resolution in a step-wise fashion to com-
pletely cover the entire mass range of interest. Collision-
induced dissociation is carried out in Q2 at high speed
and the corresponding high-resolution MS/MS spectra
are recorded covering every precursor in each cycle [28].
The combination of high resolution, sensitivity, and
throughput offers significant advantages towards the iden-
tification and quantification of lipids in complex biological
extracts.
Here in, we report a high-throughput DBS-MS/MSALL
lipidomics platform to analyze the blood lipidome via
the direct infusion of lipids extracted from DBS samples.
More than 1,200 lipid molecular species were identified
and quantified in a single dried blood spot sample. We
also explored the lipidomics profiles from four different
blood matrixes: 1) dried blood spot from a finger prick,
2) whole blood (through venous sampling), 3) plasma,
and 4) serum. In addition, DBS lipid stability at various
storage temperatures and time points was assessed. The
high-throughput DBS-MS/MSALL shotgun lipidomics
workflow demonstrated here exemplifies a robust and
formidable tool for investigation of population health
and precision medicine in diverse disease states and in-
terventions that empower individual participation and
avoids unnecessary sample waste.
Methods
Materials
All lipid standards were purchased from Nu-Chek Prep
Inc (Waterville, MN), Avanti Polar Lipids (Alabster, AL),
Cayman Chemical (Ann Arbor, MI), Matreya (State
College, PA), Cambridge Isotope Laboratories (Tewksbury,
MA), or Sigma-Aldrich (St Louis, MO). All solvents were
of HPLC or LC/MS grade and were purchased from Fisher
Scientific (Waltham, MA) or VWR International (Radnor,
PA). Whatman 903™ filter paper cards, adjusted ACCU-
CHEK lancets, and Uni-Core punch with ID 6 mm were
purchased separately from GE Healthcare (Westborough,
MA) and Roche Diagnostics (Indianapolis, IN).
Preparation of dried blood spots
Written informed consent was provided by the subjects
prior to participating in the study. Research use of sam-
ples was conducted in accordance with the terms out-
lined within the informed consent form and the terms
set forth therein and with the tenets of the Declaration
of Helsinki. Diets and other physiologic parameters were
not controlled for in this study.
For the blood matrix study, the volunteer was fasted
overnight (around 12 h) and venipuncture of a cubital
vein was performed in the morning. Blood was drawn
into a non-coated tube for whole blood, a K2 EDTA
tube (BD, Franklin Lakes, NJ) for blood plasma, and sili-
cone coated tube (BD) for blood serum. For whole blood
samples, tubes were mixed well by gentle inversion 10
times and whole blood was immediately spotted on
Whatman 903™ filter paper cards. For serum and plasma
samples, the tubes were centrifuged at 1,200 g for
15 min at room temperature and the supernatant plasma
and serum were spotted onto Whatman 903™ filter paper
cards. Concomitantly, blood via finger prick was taken
and spotted onto Whatman 903™ filter paper card. All
samples were air dried for 3 h at room temperature
(~22 °C) and collected using Uni-Core punch (ID 6 mm,
GE Healthcare) for extraction as described below.
For the DBS stability study, whole blood was drawn
and immediately spotted onto Whatman 903™ filter
paper cards. After samples were air dried completely for
3 h at room temperature, the paper cards were stored
with desiccant at different conditions: 4 °C, room
temperature, and 37 °C for 3 days, 1 week, and 2 weeks.
For the time course study, a total of 12 healthy volun-
teers (6 male and 6 female) were included (Mean age
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31 ± 6 years). After finger pricks using a single-use
safety lancet, the blood drop was directly applied onto
Whatman 903™ filter paper cards at 7 AM (after over-
night fasting), 10 AM, 1 PM (1 h after lunch), 4 PM,
and 7 PM. The blood spots were air dried completely
for 3 h at room temperature and stored at room
temperature in a zip-closure bag with desiccant.
For the DBS daily variation study, a total of 16
healthy volunteers (8 male and 8 female) were in-
cluded (Mean age 32 ± 6 years). Finger prick blood
samples were collected onto Whatman 903™ filter
paper cards in the morning after overnight fasting
over 5 consecutive days. The blood spots were air
dried completely for 3 h at room temperature and
stored at room temperature in a zip-closure bag with
desiccant.
Sample preparation and extraction
The dried blood spots were punched out uniformly
using a GE Healthcare Uni-Core punch with ID 6 mm
and transferred to glass tubes. Lipid extraction was per-
formed using a modified Bligh and Dyer as previously
described [22, 27, 29]. Four mL chloroform:methanol
(1:1, v/v) and 1.6 mL LiCl solution (50 mM) were added
to each sample with a cocktail of deuterium-labeled, or
odd chain and extremely low naturally abundant fatty acid
internal standards for diverse lipid classes (Additional file 1:
Table S1). The extraction homogenate was vortexed and
centrifuged at 1000 g for 5 min. The chloroform layer of
each extract mixture was carefully removed and saved. An
additional 2 mL chloroform was added into the MeOH/
aqueous layer of each test tube. After centrifugation,
the chloroform layer from each individual sample was
combined and dried under a nitrogen stream. Each individ-
ual residue was then re-suspended in 4 mL chloroform/
methanol (1:1), back-extracted against 1.8 mL LiCl
aqueous solution (10 mM), and the extract was dried as
described above. Such lipid extraction was automated
using a customized sequence on a Hamilton Robotics
STARlet system (Hamilton, Reno, NV) designed to
meet high-throughput requirements. Finally, lipid ex-
tracts were dried under nitrogen and reconstituted in
68 μL chloroform:methanol (1:1, v/v). Samples were
flushed with nitrogen and stored at -20 °C. The repro-
ducibility of the extraction method was evaluated by
measuring the peak area of the added internal standard
in three replicates of DBS. The recovery was obtained
by comparing the response of analyte added and ex-
tracted from the DBS to the response for the analyte in
solvent. The sensitivity was assessed as the limit of
quantification (LOQ) for each added internal standard
by measuring the serial dilution of the extracted DBS
samples (Additional file 2: Table S2).
Direct Infusion Quadruple Time of Flight (QTOF) mass
spectrometry
The concentrated samples were diluted 50× in isopro-
panol:methanol: acetonitrile:H2O (3:3:3:1, by vol.) with
2 mM ammonium acetate in LC vials, and 50 μL di-
luted lipid extract was automatically loaded and directly
delivered to the ESI source using an Ekspert microLC
200 system (Sciex) with a flow rate of 6 μL/min on a
customized sample loop. The MS/MSALL acquisition
experiment was carried out on a SCIEX TripleTOF
5600+ (Sciex). ESI source parameters included nebuliz-
ing gases GS1 at 10, GS2 at 10, curtain gas (CUR) at
15, ion spray voltage at 5000 and -4500 V for the posi-
tive and negative modes, respectively, declustering po-
tential at 100 V, and temperature at 300 °C. The
atmospheric-pressure chemical ionization (APCI) probe
and inlet were connected to a calibrant pump which
delivers mass calibration solution for MS and MS/MS.
The MS/MSALL data acquisition was controlled with
Analyst® TF 1.5.1 software (Sciex). The MS range was
200-1200 m/z at an accumulation time of 300 ms,
followed by 1000 product ion scans with 1000 precur-
sors evenly spaced from m/z 200.051 to m/z 1200.051,
measuring across m/z 200-1200 with the accumulation
time 300 ms each. The total time for one MS/MSALL
acquisition was around 8 min. Optimal collision energy
MS/MS fragmentation was 30 ± 15 eV. The identifica-
tion of lipid molecular species was based on the mo-
lecular weight, at least one specific fragments, and lipid
structure (Table 1). The acquired TOF MS and MS/
MSALL data were processed with MultiQuant 1.2.2.5
(Sciex) with the support of MS/MSALL data analysis
and the in-house database. Furthermore, the identifica-
tion of a lipid molecular species structure could be fur-
ther confirmed using PeakView® software (Sciex), if
needed. The quantification was performed by compar-
ing the peak area of molecular species to the internal
standard within a linear dynamic range with the iso-
topic corrections [30] and normalized to one DBS spot
using MultiQuant 1.2.2.5. The lipid species were
counted based on the readout obtained from Multi-
Quant as confirmed by diagnostic fragments used for
quantitation.
Statistics
The results are expressed as mean ± standard deviation
(SD). Statistical analysis comparing various blood
matrices coverage was performed using Graphpad
Prism. The analysis of lipids over time was conducted
using a repeated one-way analysis of variance ANOVA
using R programming [31]. The principal component
analysis (PCA) was carried out for the different blood
matrix study using R programming [32].
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Results
Adaption of DBS-MS/MSALL shotgun lipidomics to different
blood matrix samples
The choice of negative mode or positive mode analysis
for different lipid classes is based on the differential
propensity of each lipid class to acquire either positive
or negative charges under the source of high voltage
[15, 22, 33]. Anionic lipids, including PA, PG, PI, and
PS are acquired under the negative modes for the higher
sensitivity. The zwitterion phospholipids, such as PC, PE,
and SM, and the neutral lipids, prefer to become either
the protonated ions or ammonium added ions in the posi-
tive modes. For each different lipid class, the quantifica-
tion was carried out by either precursor ion scanning or
neutral loss scan, specific for acyl fatty acid anions, or lipid
class-specific fragment ions [22, 24]. The ionization mode,
molecular ions, and their corresponding scan modes are
summarized in Table 1.
Lipid extraction is one of the key steps to the success-
ful analysis of shotgun lipidomics by ESI/MS in general.
In this study, the modified Bligh and Dyer method was
used to extract total lipids from DBS samples and is
suited for analyzed lipid classes [22, 33]. LiCl solution
was used to improve the extraction efficiency of acidic
lipids, prevent the degradation of plasmalogen molecular
species, and decrease spectral complexity. At the final
stage, an additional Bligh and Dye extraction against an
aqueous phase with LiCl was used to further enrich the
lipid extracts. To evaluate the efficiency of DBS lipid ex-
traction, the repeatability and recovery of the extraction
was investigated using the added internal standards. The
recovery rates for most of added lipid analytes are in the
range of 50 to 100% with satisfactorily reproducible
measurements (coefficient of variation [CV] <10% for
most added lipid analytes) (Additional file 2: Table S2).
The sensitivity of the MSMSALL shotgun lipidomics, rep-
resented by LOQ, ranging from 0.10 to 1.62 nM, is con-
sistent with the previous reports [22, 23, 27, 28, 33].
To investigate the difference between DBS and other
blood matrices, four blood matrices were assessed in this
study: 1) whole blood (venous drawn), 2) plasma, 3)
serum, and 4) finger pricked blood, the direct DBS. All
samples were spotted onto Whatman 903™ filter paper
cards (Fig. 1a). After 3 h, the spots were uniformly
punched out and extracted using an automatic lipid ex-
traction protocol using the Hamilton robotic system.
Shotgun lipidomic analysis was performed using a cus-
tomized high-resolution Triple-TOF system with data
independent acquisition-MS/MSALL strategy [28]. Identi-
fication of lipid molecular species was based on the mo-
lecular weight, specific fragments, and a customized
lipid database. Quantification was carried out by com-
paring the peak area of molecular species to the internal
standard within a linear dynamic range. Appropriate di-
lution was performed to ensure the data was within the
linear dynamic range and to minimize the aggregation of
lipids in the solution. PCA analysis for different blood
matrices (Fig. 1b) demonstrated similarity between the
DBS and the whole blood, which is clearly separated
from the plasma and serum. More than 1,200 lipid mo-
lecular species were determined in each blood matrix
(Fig. 1c). Furthermore, the lipid class distribution (Fig. 1d)
provided consistent results demonstrating finger prick
DBS was analogous to whole blood samples, as they both
contained more phospholipids but less triacylglyceride
(TAG) than plasma and serum. Since the variation of sin-
gle lipid molecular species is dependent on the concentra-
tion of the species and the coefficient of variation (CV)
increases as the concentration decreases due to interfer-
ence of background noise [34], we use total content of
each lipid class to investigate the stability of lipids across
all the blood matrices. The CV of each lipid class (includ-
ing lyso molecular species) was used to assess the repro-
ducibility for all four blood matrices (Fig. 1e). With the
exception of phosphatidylinositol (PI) identified in whole
blood sample, the CV for all the other lipid classes in
various matrices examined were below 25%, which is
acceptable for omics biomarker discovery studies [34].
Short-term stability of DBS
One of the advantages of DBS samples is improved ana-
lyte stability over a wide range of temperatures during
storage and transportation [5, 6]. Here, we stored DBS
samples at 4 °C, room temperature (RT), and 37 °C for
3 days, 1 week, and 2 weeks. The stability was deter-
mined by comparing the concentrations of each lipid
class against those of the control samples (day 0) (Fig. 2).
Table 1 Summary of polarity and scan modes for lipid classes
using ESI-MS/MSALL
Lipid Classa Polarity Molecular Ion MS/MS Scan Mode
PC positive M + H Precursor ion of 184.1
PE positive M + H Neutral loss of 141.0
SM positive M + H Precursor ion of 184.1
TAG positive M + NH4 Neutral loss of FA
b
DAG positive M + NH4 Neutral loss of FA
Cer positive M + H Precursor ion of 264.2
AC positive M + H Precursor ion of 85.0
Glycolipid positive M + H Precursor ion of 264.2
PA negative M-H Precursor ion of FA
PS negative M-H Precursor ion of FA
PI negative M-H Precursor ion of FA
PG negative M-H Precursor ion of FA
aPC phosphatidylcholine, PE phosphatidylethanolamine, PS phosphatidylserine,
SM sphingomyelin, PI phosphatidylinositol, PG phosphatidylglycerol,
PA phosphatidic acid, TAG triacylglyceride, DAG diacylglyceride, Cer ceramide,
AC acylcarnitines, bFA fatty acid
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For almost all of phospholipids and glycolipids classes, rela-
tive change was less than 20% when samples were stored at
4 °C or RT for up to 2 weeks, except for diacylglyceride
(DAG). In contrast, storing at a temperature of 37 °C im-
pacted the stability for the vast majority of lipid classes, as
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Fig. 1 Adaption of dried blood spots (DBS)-MS/MSALL Lipidomics to different blood matrices. (a) Scheme of DBS-Lipidomics for blood matrices;
(b) Principle component analysis (PCA) of the lipidomics data from the different blood matrices; (c) The number of detectable lipid molecular
species in different lipid classes; (d) Lipid class percentage distribution of total lipids in different blood matrices; (e) Reproducibility of lipid
classes for different blood matrices (n = 8). c and d were run using one-way ANOVA with Dunnett’s post hoc test against DBS for each lipid
class with *p-value < 0.05, **p-value < 0.01, and ***p-value < 0.001. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine;
SM, sphingomyelin; PI, phosphatidylinositol; PG, phosphatidylglycerol; PA, phosphatidic acid; TAG, triacylglyceride; DAG, diacylglyceride; Cer, ceramide;
AC, acylcarnitines; Glyco, glycolipids; CoQ10, Coenzyme Q
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Postprandial triglyceride profiling by DBS-MS/MSALL
lipidomics
Dynamic assessment of triglyceride content and molecu-
lar species in real-time without the need for clinical
sample collection represents a promising approach to
monitor triglyceride homeostasis in response to diet and
clearance. Using the DBS-MS/MSALL lipidomics plat-
form, we can measure not only the postprandial total
TAG responses (Insert in Fig. 3a), but also identify and
quantitate the level of TAG molecular species (Fig. 3a).
For a designated TAG molecular species representative
(e.g. TAG 52:4), through the MS/MS fragmentation and
high-resolution capabilities (Fig. 3b), we identified the
fatty acid components of TAG molecular species, and
demonstrated the unique dynamic measurement of fatty
acid building blocks during the course of the day for an
individual molecular species (Fig. 3c).
Temporal profiling of lipid species over time in a day
using DBS-MS/MSALL shotgun lipidomics
To study the temporal fluctuation of lipid species, 12
volunteers were recruited and DBS collection was per-
formed. During the day, 5 time points (7 AM, 10 AM,
1 PM, 4 PM, and 7 PM) were collected, extracted, and
analyzed using DBS-MS/MSALL lipidomics. The negative
log10 (p-value) was plotted against each individual lipid
molecular species (Fig. 4a) to search for the most dy-
namic lipid molecules that are altered over the course
of a day. The profile of lipid species with the smallest
p-values, i.e. those that were significantly altered over-
time are illustrated in Fig. 4b, which depicts lysopho-
sphatidylcholine (LPC) 26:0, LPC 24:0, and LPC 22:0
concentration change is greatest between 10 AM and
4 PM and lowest between 7 PM and 7 AM, whereas
phosphatidylethanolamine (PE) 34:1 levels decreased
between 10 AM and 4 PM and increased between
7 AM and 7 PM. For LPC 26:0 and LPC 24:0, MS/MS
spectra and fragmentation patterns of LPC 26:0 and
LPC 24:0 were provided to support the identification
(Additional file 3: Figure S1). In addition, we performed
the same analysis for lipid classes (Additional file 4:
Figure S2) and found that lipid classes, PE, sphingomyelin
(SM), and Coenzyme Q (CoQ), varied significantly over
the course of time within a day (p value < 0.05). Thus,
given the dynamic changes in these lipid species and clas-
ses over the course of the day these results demonstrate
that these lipid entities may be affected by circadian
rhythms or dietary interactions and should be viewed with
caution with respect to biomarker development.
Temporal changes of fasted samples collected over
5 days using DBS-MS/MSALL lipidomics
To assess the intrinsic day to day variation of the lipid mo-
lecular species using DBS MS/MSALL shotgun lipidomics
analysis, sixteen healthy volunteers were recruited and
DBS were collected over the course of 5 successive morn-
ings after overnight fasting. The negative log10 (p-value)
are plotted for each individual lipid molecular species
(Fig. 5a). The profile of lipid species with the smallest
p-values that are affected over time is illustrated in
Fig. 5b. For lipid classes, only phosphatidylcholine (PC)
showed significant changes across the week (Additional
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Fig. 2 Assessment of short-term stability of dried blood spots (DBS)-MS/MSALL Lipidomics. (a) Phospholipids; (b) Glycerides, glycolipids, and lipid
metabolites. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; SM, sphingomyelin; PI, phosphatidylinositol;
PG, phosphatidylglycerol; PA, phosphatidic acid; TAG, triacylglyceride; DAG, diacylglyceride; Cer, ceramide; AC, acylcarnitines; Glyco, glycolipids;
CoQ, Coenzyme Q
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Across the different time scales we identified 253 lipids
species that are significantly altered over the course of
hours within the day (p values <0.05), which accounts
for 19% of the total lipids detected, while 109 lipid mole-
cules (8% of total measured lipids) were altered over the
course of 5 days (Fig. 6a). Alterations of 12 species were
found to overlap across both time scales (hours within a
day and days across a week), which include multiple
lipid classes, such as glycolipid, PC, phosphatidylglycerol
(PG), and TAG (Fig. 6b).
Discussion
Dried blood spot (DBS) analysis is a convenient way to
collect blood samples with several advantages over con-
ventional blood collection methods. DBS has gained




Fig. 3 Postprandial triacylglyceride (TAG) profile using blood spots (DBS)-MS/MSALL Lipidomics. (a) Postprandial profile of TAG molecular species
(insert: total TAG levels); (b) Identification of TAG 52:4 based on MS/MS fragmentation spectrum; (c) Temporal changes of TAG 52:4 with fatty
acid components
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studies, and therapeutic drug monitoring [2, 4, 7, 8]. DBS
coupled with LC-MS/MS system provides the capacity to
analyze samples in a high throughput manner once
coupled to robust analytical methods. Lipidomics analysis
of whole blood, which is comprised of thousands of di-
verse lipid molecular species, is directly linked to an in-
dividual’s physiological, nutritional and health status
[14, 35]. In this study, we combined DBS collection
with high-resolution MS/MSALL shotgun lipidomics
analysis to analyze the blood lipidome. We demonstrate
in one DBS spot, several lipid classes and more than
1,200 lipid species were identified and quantified.
Direct infusion-based MS shotgun lipidomics provides
comprehensive profiling and quantitation of lipid species
from organic extracts of biological samples without the
LC column separation [22]. Conventionally, numerous
tandem MS strategies have to be applied for different
lipid classes, such as precursor ion scanning and neutral
loss scanning, and it requires the pre-selection of target
lipids and fragmentations. On the other hand, the high-
resolution MS/MSALL method, which utilizes DIA ana-
lysis, does not require any pre-selection and records all
information in high resolution MS/MS spectra, thus
allowing for data interpretation following the analysis
(A)
(B)
Fig. 4 Temporal changes of lipid species over hours within a day. (a) The scatter plot of negative log10 (p) vs the lipid species, analyzed by repeated
one-way ANOVA (subject = 12, 5 time points); (b) The profiles of the molecular species with the lowest p values over time. The DBS samples were
collected at 7 AM, 10 AM, 1 PM, 4 PM, and 7 PM. LPC lysophosphatidylcholine, PE phosphatidylethanolamine
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[28]. It is noteworthy to mention that the MS/MSALL ap-
proach employs 1 m/z isolation window instead of the
wider windows, because the wider isolation windows
result in the disconnection between the fragment ions
and precursors, complicating the analysis of the acquired
data [25]. Using the 1 Da isolation window not only
(A)
(B)
Fig. 5 Temporal fluctuation of lipid species over days. (a) The scatter plot of negative log10 (p) vs the lipid species, generated by the repeated
one way ANOVA analysis (subject = 16, 5 days); (b) The profiles of the molecular species with the lowest p values over time. The DBS samples
were collected in the 5 successive morning after overnight fasting. MonoHex monohexose, PC phosphatidylcholine, TAG triacylglyceride
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allows us to collect all the fragments from the precur-
sors, but maintains the relationship between the frag-
ments and the precursor ions, which facilitates the
identification of lipid molecular species through data
processing. Collectively, the MS/MSAll approach is bias-
free and delivers the high specificity with informative pro-
duction ion spectra and high sensitivity with the limit of
quantitation (LOQ) as low as the sub nM or nM range
for most of lipids, and offers a solution for measuring
the lipidomes in diverse clinical samples using a high
throughput approach that enables application of lipido-
mics in broader population-based analysis.
The era of precision medicine is now taking center
stage, accelerating the stratification of patients based on
their molecular signatures [36]. Genomics alone, however,
will not be able to selectively define all patient populations
prone to a disease or therapeutic response. Proteomic,
metabolomic, and lipidomic workflows are emerging dy-
namic “omics” technology, which can be complementary
to genomics. Thus, illuminating the complexity of envir-
onmental exposure and phenotype of health as well as dis-
ease states [37, 38].
In this study the postprandial TAG molecular species
and the entire lipidome identified by the DBS-MS/
MSALL lipidomics platform delivered important insight
that enables the potential for personal lipidomics profil-
ing to monitor physiological changes, which could be
applied to the diagnosis and presence of disease. It is
notable that there are higher variations of lipid molecu-
lar species within the day than within the week (across
days) (Fig. 6a), which indicates that internal factors (such
as circadian rhythms), and external factors (i.e. diet)
have a profound effect on the blood lipid profiles. This is
not surprising given that several lipid classes and species
have been demonstrated to show diurnal variation in
animal and human studies [39]. Thus, these data impli-
cate the need to consider time of day/circadian rhythm
when assessing specific lipid species for comparisons
across individuals. However, the consistency of the lipid
profiles across days implies that fasted blood samples are
more stable across days when assessed at the same time
among various individuals. The lipid molecular signatures
from the temporal changes of lipid species over different
time periods (hours vs days) using DBS-MS/MSALL lipido-
mics demonstrates the feasibility to use this technique for
biomarker discovery in population-based studies and
highlights the innate temporal changes of the lipidome in
diverse individuals. Taken together, the DBS-MS/MSALL
lipidomics platform, with its simple blood collection and
high throughput capacity could be applied for future
large-scale population based lipidome profiling.
As a less invasive sampling method DBS offers a sim-
ple collection protocol, requires a significantly smaller
blood volume than venous sampling, and is easy to store
and transfer, which thereby reduces the infection risk to
various pathogens [5, 6, 40]. DBS coupled with LC-MS/
MS provides a highly sensitive and selective method for
quantitative analysis of small molecules, lipids, peptides,
and proteins [8, 11, 41]. The challenges for developing
DBS-LC-MS/MS methods include the lack of extensive
references for most molecules using DBS for blood sam-
pling, the discrepancy among blood and plasma/serum,
and the possible interaction of blood and/or analytes
with the matrix of a DBS card [40, 42], which were ad-




Fig. 6 a Venn diagram of lipid molecular species significantly changed (p
values < 0.05) within a day and across days; b Lipid species significantly
changed within a day and across days. MonoHex, monohexose;
BiHex, bihexoses; TriHex, trihexoses; PC, phosphatidylcholine; LPC,
lysophosphatidylcholine; PG, phosphatidylglycerol; TAG, triacylglyceride
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Conclusions
In summary, here in we developed a novel DBS-MS/
MSALL shotgun lipidomics workflow to profile the hu-
man blood lipidome. In a single DBS spot, multiple lipid
classes and more than 1,200 lipid species were identified
and quantified. The application of this method to the
postprandial lipidomics profiles and the temporal changes
of lipids over time demonstrated the potential for use in
preclinical and clinical studies, as well as for population-
based health studies. Analysis of an individual’s lipidome
using this novel platform provides a valuable approach for
monitoring health status in real-time and provides a com-
prehensive profile of a person’s lipid homeostatic state.
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